DELAET INGRID (Chief Regulatory Officer) sold 12.2% of their position (2.26K shares) of NEUROCRINE BIOSCIENCES INC on the open market
Open‑market sale worth $354.3K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 6/2/2026ACC: 0001965808-26-000007
Officer· Chief Regulatory Officer
Since Feb 2026
-2.26K
Net shares
Net seller
$354.3K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
2.26K acquired · 4.52K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+2.26K
Price / share
$79.02
Trade value
$178.66K
% of position
13.9%
5/29/2026
16.23K→18.49K
Common Stock
Direct
Shares
−2.26K
Price / share
$156.71
Trade value
$354.32K
% of position
12.2%
5/29/2026
18.49K→16.23K
Total
Net shares
+0.00
Net value
-$175.66K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/29/2026 | M · Option Exercise | +2.26K | $79.02 | $178.66K | 13.9% | 16.23K | 18.49K |
| Common Stock Direct | 5/29/2026 | S · Sale | −2.26K | $156.71 | $354.32K | 12.2% | 18.49K | 16.23K |
| Total | +0.00 | -$175.66K | ||||||
Derivative Transactions1
Non-Qualified Stock Option
Direct
Converts to
Common Stock
2.26K shares
Shares
−2.26K
Strike price
79.02
Held after
0.00
Exercisable
—
5/29/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Non-Qualified Stock Option Direct | Common Stock2.26K shares | 5/29/2026 | M · Option Exercise | −2.26K | 79.02 | — | 0.00 |